ESLA ▲ +3.2% - Estrella Immunopharma, Inc.
$ESLA Estrella Immunopharma Activates Intermountain Health LDS Hospital as Fifth Clinical Site for Phase I/II STARLIGHT-1 Trial in B-cell Non-Hodgkin’s Lymphoma
14-OCT-2026 04:19 PM ET
Share this post
More filings for $ESLA
ESLA ▲ +62.5% - Estrella Immunopharma, Inc.Oct 15, 2026ESLA - Estrella Immunopharma, Inc. - SEC Filing Update (14-AUG-2026) | ThinkSabio - Stocks SimplifiedAug 14, 2026
View full $ESLA filing history →💬 Comments
Loading comments…
Leave a comment